AAAAAA
Results:
1-14
|
Results: 14
Authors:
Bruskin, A
Tolmachev, V
Westlin, JE
Lundqvist, H
Citation: A. Bruskin et al., Separation of two labeled components of [In-111]-OctreoScan by HPLC, J RAD NUCL, 247(1), 2001, pp. 95-99
Authors:
Hartman, T
Lundqvist, H
Westlin, JE
Carlsson, J
Citation: T. Hartman et al., Radiation doses to the cell nucleus in single cells and cells in micrometastases in targeted therapy with I-131 labeled ligands or antibodies, INT J RAD O, 46(4), 2000, pp. 1025-1036
Authors:
Bue, P
Holmberg, AR
Marquez, M
Westlin, JE
Nilsson, S
Malmstrom, PU
Citation: P. Bue et al., Intravesical administration of EGF-dextran conjugates in patients with superficial bladder cancer, EUR UROL, 38(5), 2000, pp. 584-589
Authors:
Ljung, G
Lennernas, B
Nordgren, H
Holmberg, A
Westlin, JE
Nilsson, S
Edgren, M
Citation: G. Ljung et al., Human milk fat globule antigen 1 (HMFG1) expression in prostatic carcinomaand immunotargeting with a radiolabelled monoclonal anti-HMFG1 antibody, ANTICANC R, 20(4), 2000, pp. 2321-2324
Authors:
Kalkner, KM
Westlin, JE
Strang, P
Citation: Km. Kalkner et al., (89)strontinm in the management of painful sceletal metastases, ANTICANC R, 20(2B), 2000, pp. 1109-1114
Authors:
Janson, ET
Westlin, JE
Ohrvall, U
Oberg, K
Lukinius, A
Citation: Et. Janson et al., Nuclear localization of In-111 after intravenous injection of [In-111-DTPA-D-Phe(1)]-octreotide in patients with neuroendocrine tumors, J NUCL MED, 41(9), 2000, pp. 1514-1518
Authors:
Edgren, M
Westlin, JE
Kalkner, KM
Sundin, A
Nilsson, S
Citation: M. Edgren et al., [In-111-DPTA-D-Phe(1)]-octreotide scintigraphy in the management of patients with advanced renal cell carcinoma, CANC BIO R, 14(1), 1999, pp. 59-64
Authors:
Holmberg, AR
Wilchek, M
Marquez, M
Westlin, JE
Du, J
Nilsson, S
Citation: Ar. Holmberg et al., Ion exchange tumor targeting: A new approach, CLIN CANC R, 5(10), 1999, pp. 3056S-3058S
Authors:
Janson, ET
Kalkner, KM
Eriksson, B
Westlin, JE
Oberg, K
Citation: Et. Janson et al., Somatostatin receptor scintigraphy during treatment with lanreotide in patients with neuroendocrine tumors, NUCL MED BI, 26(8), 1999, pp. 877-882
Authors:
Carlsson, J
Blomquist, E
Gedda, L
Liljegren, A
Malmstrom, PU
Sjostrom, A
Sundin, A
Westlin, JE
Zhao, QH
Tolmachev, V
Lundqvist, H
Citation: J. Carlsson et al., Conjugate chemistry and cellular processing of EGF-Dextran, ACTA ONCOL, 38(3), 1999, pp. 313-321
Authors:
Lundqvist, H
Lubberink, M
Tolmachev, V
Lovqvist, A
Sundin, A
Beshara, S
Bruskin, A
Carlsson, J
Westlin, JE
Citation: H. Lundqvist et al., Positron emission tomography and radioimmunotargeting - General aspects, ACTA ONCOL, 38(3), 1999, pp. 335-341
Authors:
Lubberink, M
Lundqvist, H
Westlin, JE
Tolmachev, V
Schneider, H
Lovqvist, A
Sundin, A
Carlsson, J
Citation: M. Lubberink et al., Positron emission tomography and radioimmunotargeting - Aspects of quantification and dosimetry, ACTA ONCOL, 38(3), 1999, pp. 343-349
Authors:
Janson, ET
Eriksson, B
Oberg, K
Skogseid, B
Ohrvall, U
Nilsson, S
Westlin, JE
Citation: Et. Janson et al., Treatment with high dose [In-111-DTPA-D-PHE1]-octreotide in patients with neuroendocrine tumors - Evaluation of therapeutic and toxic effects, ACTA ONCOL, 38(3), 1999, pp. 373-377
Authors:
Lukinius, A
Ohrvall, U
Westlin, JE
Oberg, K
Janson, ET
Citation: A. Lukinius et al., In vivo cellular distribution and endocytosis of the somatostatin receptor-ligand complex, ACTA ONCOL, 38(3), 1999, pp. 383-387
Risultati:
1-14
|